Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

FIND, a co-op partner of the World Health Organization, has included Selfdiagnostics in their 2017-2020 project pipeline for tuberculosis diagnostics. Selfdiagnostics is one of the TOP 20 projects in the Sputum-based and drug susceptibility testing area that was given this priority status. FIND has referenced Selfdiagnostics’ technology – a lab level accurate and fully disposable rapid…

Selfdiagnostics was invited to attend the conference Innovation TRIFFT Investition (Innovation meets Investment) 2017 in Dresden 22 – 23 of June 2017 by the Minister President of Saxony Mr Stanislaw Tillich. Part of Selfdiagnostics’ R&D is based in Leipzig and we are very grateful for such acknowledgement of our work. The goal of the conference…

Selfdiagnostics Begins Production of First Molecular Diagnostic Home Test in the World after Completing Multiplexed Sexually Transmitted Diseases Product Design. Selfdiagnostics is pleased to announce that the company has successfully achieved a strategically important milestone by freezing product design of multiplexed sexually transmitted diseases MDx test. Selfdiagnostics will now move on with preparations for product…

In addition to the existing 3 applications Selfdiagnostics has filed previously, further 3 applications have been submitted in March 2017. One of the applications is in progress. All 7 patents will enable the company to protect its core technology from replication; guaranteeing continued company value and growth in the coming years.

Selfdiagnostics was presented as one of the 8 “Swimming with the Sharks” finalists at the 14th Annual Molecular Diagnostics Conference in San Francisco, USA on the 22nd February 2017 and was a one of the three winners. Our selection in this event as one of the best company demonstrates our recognition as a promising MedTech…

Page 2 of 2 1 2